Thursday, Vaccinex, Inc. (VCNX) announced a reverse stock split of its common stock, which will be effective from 5:00 p.m. Eastern Time on Monday, February 19, 2024.The reverse stock split will be in a ratio of 1-for-14, and as of February 20, 2024, the Company's common stock will be traded on a split-adjusted basis.

周四，Vaccinex，Inc.（VCNX）宣布对其普通股进行反向股票分割，该分割将于2024年2月19日（星期一）东部时间下午5:00生效。反向股票分割将以14比1的比例进行，截至2024年2月20日，该公司的普通股将在分割调整的基础上进行交易。

The reverse stock split has been put in place by the Company to comply with the $1.00 minimum bid price requirement of The Nasdaq Capital Market. For comments and feedback contact: editorial@rttnews.comBusiness News.

该公司已实施反向股票分割，以符合纳斯达克资本市场1美元的最低出价要求。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In November 2023

2023年11月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In October 2023

2023年10月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision in August 2023

2023年8月美国食品和药物管理局（FDA）决定生物技术股